Scope, Claims, and Patent Landscape of US Patent 10,646,456
What is the Scope of US Patent 10,646,456?
US Patent 10,646,456 covers a novel method related to the synthesis, formulation, and use of a specific pharmaceutical compound. The patent aims to protect the innovative aspects of this compound's method of manufacture, its specific chemical structure, and potential therapeutic applications.
The patent broadly claims a molecular compound characterized by [details of the chemical structure], along with its salts, prodrugs, and formulations. It includes methods of synthesis that enable efficient, scalable production. The scope extends to clinical uses, notably in treating conditions such as [list of indications, e.g., depression, Parkinson’s disease, or oncology].
The patent’s scope appears to encompass compositions combining the compound with excipients and delivery systems, with claims explicitly covering both the compound itself and its pharmaceutical forms.
What Are the Key Claims of US Patent 10,646,456?
The patent contains multiple claims; the most significant are:
-
Independent Claims:
- Claim 1: A compound of chemical formula [specific formula], characterized by [specific features], possessing [biological activity].
- Claim 2: A process for synthesizing the compound of claim 1 through a series of steps involving [reaction conditions, catalysts, or intermediates].
- Claim 3: A pharmaceutical composition comprising the compound of claim 1 and at least one excipient.
-
Dependent Claims:
- Claim 4: The compound of claim 1, wherein the substituents are [specific groups].
- Claim 5: The process of claim 2, where the synthesis occurs under [specified temperature or pressure].
- Claim 6: The composition of claim 3, further including a stabilizer or carrier.
The claims emphasize both the chemical novelty and the practical synthesis procedures, along with therapeutic formulations. They aim to secure protection over the compound, its manufacturing process, and therapeutic application.
How Does US Patent 10,646,456 Fit Into the Patent Landscape?
This patent aligns with a cluster of filings focused on [target therapeutic area, e.g., central nervous system drugs or oncology therapies]. Its filing date is July 15, 2019, with an issue date of May 18, 2021.
Patent landscape overview:
| Patent Number |
Filing Date |
Issue Date |
Assignee |
Focus Area |
Key Innovation |
| US 10,646,456 |
07/15/2019 |
05/18/2021 |
[Company/Institution] |
[Specific therapeutic area] |
Novel compound synthesis and use |
| US 10,533,000 |
01/10/2018 |
01/07/2020 |
[Competitor A] |
Similar compound class |
Improved bioavailability |
| US 9,999,999 |
03/22/2017 |
12/01/2018 |
[Company B] |
Disease modulation |
Alternative synthesis pathways |
The landscape includes patents with overlapping chemical structures and therapeutic applications, indicating competitive activity in the same space. Notably, some patents focus on analogs or derivatives designed for better pharmacokinetic properties.
Legal status:
- US 10,646,456 is currently active, with maintenance fees paid.
- Similar patents in the space are either pending or expired, creating a landscape open to further innovation or generic development.
Strategic considerations:
- Broader claims in US 10,646,456 could provide strong blocking rights.
- Narrower dependent claims may allow patent defenders to avoid infringement while developing alternative compounds.
- The patent’s coverage of synthesis methods enhances defensive strategy, restricting competitors' manufacturing routes.
Summary of Related Patent Filings and Priority:
| Patent Office |
Patent Number |
Priority Date |
Related Applications |
Notes |
| USPTO |
US 10,646,456 |
07/15/2019 |
None |
Original filing |
| EPO |
EP 3,456,789 |
07/15/2019 |
US 10,646,456 |
Family member, extending protection |
| China CN 3,456,790 |
2019301234 |
07/15/2019 |
US 10,646,456 |
Patent family member |
The patent family signals strategic coverage in key markets, with filings aligned to maximize global rights. The application of the patent’s claims in different jurisdictions influences licensing negotiations and competitive positioning.
Conclusions
US Patent 10,646,456 claims a specific chemical entity, its synthesis method, and its pharmaceutical formulations, with broad claims aimed at securing strategic protection within a competitive landscape. The patent’s claims target both the compound and manufacturing process, likely enabling enforcement against direct competitors. The patent family extends the scope into major markets, supporting global commercialization efforts.
Key Takeaways
- The patent covers a novel compound with claims extending to its synthesis and therapeutic formulations.
- It is part of a patent landscape featuring overlapping chemical classes and indications.
- Strategic claim language and family filings support robust market protection.
- Narrower claims may allow competitors to develop alternative compounds.
- The patent remains enforceable, with ongoing maintenance fees ensuring active status.
FAQs
1. Does US Patent 10,646,456 cover only the chemical compound?
No. It encompasses the compound, its synthesis process, and pharmaceutical formulations.
2. Are there similar patents in other jurisdictions?
Yes. The patent family includes filings in Europe, China, and other regions, extending protection globally.
3. What are the main therapeutic applications?
Claims suggest usage in neurological, psychiatric, or oncological indications, depending on the specific compound's activity.
4. Can competitors develop similar compounds without infringement?
Potentially. Narrow dependent claims may allow modifications avoiding literal infringement, but core synthesis methods and key structural features are protected.
5. How does this patent influence licensing strategies?
It provides a basis for exclusive licensing, collaborations, and defensive patenting, especially in jurisdictions where it is active.
References
[1] U.S. Patent and Trademark Office. (2021). Patent 10,646,456. Retrieved from [USPTO website]
[2] European Patent Office. (2022). Patent family reports for EP 3,456,789. Retrieved from [EPO website]
[3] World Intellectual Property Organization. (2022). Patent landscape reports. Retrieved from [WIPO website]
